Abufene tablets 400 mg 2 blisters of 15 pcs.

• active ingredient: 1 tablet contains beta-alanine 400 mg;
• excipients: magnesium stearate, glycerol palmitostearate, colloidal silicon dioxide, wheat starch.

Increased individual sensitivity to the components of the drug. Increased sensitivity or intolerance to gluten, as the drug contains wheat starch.

Abufene is to be used internally. Take 1 to 2 tablets per day (before the main meal). This dose can be increased to 3 tablets per day.

The minimum course of treatment is from 5 to 10 days (until the hot flashes stop).

If hot flashes resume, treatment can be continued throughout the entire period of clinical vasomotor disorders, without any time limit.

The drug is recommended for use in premenopause, menopause of various etiologies and postmenopausal period, before hormone replacement therapy and in combination with hormone replacement therapy. Unlike other drugs, beta-alanine does not lead to fluid retention and weight gain. No signs of addiction to the drug have been identified. There is no sedative effect. In case of adverse skin reactions (rash, itching), treatment should be discontinued.

Use during pregnancy or breastfeeding

Do not use the drug during pregnancy or breastfeeding.

Children

The drug should not be used in children. 

Ability to influence reaction speed when driving vehicles or other mechanisms

No effect.

No cases of overdose have been noted.

There may be isolated cases of the following adverse reactions: paresthesia, usually in the extremities; allergic reactions, including skin and mucous membrane rashes, skin redness, itching, urticaria; bruising.

Does not interact with hormones. Can be used in combination with neuroleptics or weak barbiturates.

Store out of the reach of children at a temperature not exceeding 25 °C.